Moldova vs Oman: Previously treated cases tested for RR-/MDR-TB
Moldova
100.0%
in 2024
Oman
100.0%
in 2024
Moldova rank
1st
Oman rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Moldova
- Oman
How they compare
Moldova currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
Across all 19 years both countries report, Oman has been ahead every year.
Moldova ranks 1st and Oman ranks 1st of 180 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Moldova | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.6% | 100.0% | 37.4% | Oman |
| 2010s | 63.6% | 96.9% | 33.3% | Oman |
| 2020s | 97.2% | 100.0% | 2.8% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Moldova or Oman?
- Moldova, at 100.0% against 100.0% in Oman as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Moldova and Oman?
- 0.0%, with Moldova ahead.
- How many years of comparable data are there for Moldova and Oman?
- 19 years are reported by both, from 2005 to 2024.
- How do Moldova and Oman rank globally for previously treated cases tested for rr-/mdr-tb?
- Moldova ranks 1st and Oman ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.